Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation

IntroductionHuman adipose tissue-derived stem cells (hASCs) are attractive cells for therapeutic applications and are currently being evaluated in multiple clinical trials. Prior to their clinical application, hASCs must be expanded ex vivo to obtain the required number of cells for transplantation. Fetal bovine serum is the supplement most widely used for cell culture, but it has disadvantages and it is not safe for cell therapy due to the risks of pathogen transmission and immune reaction. Furthermore, the cell expansion poses a risk of accumulating genetic abnormalities that could lead to malignant cell transformation. In this study, our aim was to evaluate the proliferation pattern as well as the resistance to spontaneous transformation of hASCs during expansion in a xeno-free culture condition.MethodshASCs were expanded in Dulbecco’s modified Eagle’s medium supplemented with pooled allogeneic human serum or fetal bovine serum to enable a side-by-side comparison. Cell viability and differentiation capacity toward the mesenchymal lineages were assessed, along with immunophenotype. Ki-67 expression and the proliferation kinetics were investigated. The expression of the transcription factors c-FOS and c-MYC was examined with Western blot, and MYC, CDKN2A, ERBB2 and TERT gene expression was assessed with quantitative PCR. Senescence was evaluated by β-gal staining. Karyotype analysis was performed and tumorigenesis assay in vivo was also evaluated.ResultsThe hASCs expanded in medium with pooled allogeneic human serum did not show remarkable differences in morphology, viability, differentiation capacity or immunophenotype. The main difference observed was a significantly higher proliferative effect on hASCs cultured in pooled allogeneic human serum. There was no significant difference in C-FOS expression; however, C-MYC protein expression was enhanced in pooled allogeneic human serum cultures compared to fetal bovine serum cultures. No difference was observed in MYC and TERT mRNA levels. Moreover, the hASCs presented normal karyotype undergoing senescence, and did not form in vivo tumors, eliminating the possibility that spontaneous immortalization of hASCs had occurred with pooled allogeneic human serum.ConclusionsThis complete characterization of hASCs cultivated in pooled allogeneic human serum, a suitable xeno-free approach, shows that pooled allogeneic human serum provides a high proliferation rate, which can be attributed for the first time to C-MYC protein expression, and showed cell stability for safe clinical applications in compliance with good manufacturing practice.

[1]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[2]  K. Drzewiecki,et al.  Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. , 2013, Cytotherapy.

[3]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[4]  Seung Il Kim,et al.  Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy. , 2014, Experimental and molecular pathology.

[5]  S. Gronthos,et al.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Yamaguchi,et al.  Constitutive Expression of Human Telomerase Enhances the Proliferation Potential of Human Mesenchymal Stem Cells , 2012, BioResearch open access.

[7]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[8]  Weiqing Wang,et al.  Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity , 2012, Clinical endocrinology.

[9]  V. Beneš,et al.  Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process , 2008, PloS one.

[10]  B. Cousin,et al.  Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. , 2011, World journal of stem cells.

[11]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[12]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[13]  A. Sbarbati,et al.  Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. , 2008, Stem cells and development.

[14]  T. Jensen,et al.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.

[15]  B. Nilsson,et al.  Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells? , 2014, PloS one.

[16]  A. Cometa,et al.  Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.

[17]  R. Walker,et al.  Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. , 1997, Blood.

[18]  Kathryn A. O’Donnell,et al.  Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis , 2006, Molecular and Cellular Biology.

[19]  H. Harn,et al.  Genetic and Epigenetic Instability of Stem Cells , 2014, Cell transplantation.

[20]  F. Guilak,et al.  Human adipose-derived cells: an update on the transition to clinical translation. , 2012, Regenerative medicine.

[21]  A. Cometa,et al.  Ex vivo expansion of mesenchymal stromal cells. , 2011, Best practice & research. Clinical haematology.

[22]  A. Cometa,et al.  Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms , 2010 .

[23]  K. Masuda,et al.  HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study , 2015, Gastric Cancer.

[24]  D. García-Olmo,et al.  Treatment of enterocutaneous fistula in Crohn’s Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion , 2008, International Journal of Colorectal Disease.

[25]  L. Muul,et al.  Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. , 2002, Human gene therapy.

[26]  D. Balomenos,et al.  Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. , 2009, Neoplasia.

[27]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[28]  R. Suuronen,et al.  Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. , 2009, International journal of oral and maxillofacial surgery.

[29]  M. Lindberg,et al.  Adipose Tissue , 2018 .

[30]  Louis Casteilla,et al.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). , 2013, Cytotherapy.

[31]  H. Klüter,et al.  Human AB Serum and Thrombin‐Activated Platelet‐Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue , 2007, Stem cells.

[32]  J. Laine,et al.  N‐Glycolylneuraminic Acid Xenoantigen Contamination of Human Embryonic and Mesenchymal Stem Cells Is Substantially Reversible , 2007, Stem cells.

[33]  J. Cigudosa,et al.  Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. , 2010, Experimental cell research.

[34]  R. Bjerkvig,et al.  Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. , 2010, Cancer research.

[35]  K. Tarte,et al.  Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. , 2013, Cytotherapy.

[36]  Hélène Rouard,et al.  Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. , 2010, Blood.

[37]  Su-jin Kim,et al.  Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. , 2008, Stem cells and development.

[38]  Shu-Ching Hsu,et al.  Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Katrine Frønsdal,et al.  In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability , 2005, Stem cells.

[40]  F. Gage,et al.  Human embryonic stem cells express an immunogenic nonhuman sialic acid , 2005, Nature Medicine.

[41]  R. Suuronen,et al.  The Potential of Adipose Stem Cells in Regenerative Medicine , 2011, Stem Cell Reviews and Reports.

[42]  H. Northoff,et al.  Expression of blood group genes by mesenchymal stem cells , 2011, British journal of haematology.

[43]  P. Bugert,et al.  Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. , 2010, Tissue engineering. Part A.

[44]  Y. Ishii,et al.  Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. , 2009, Biochemical and biophysical research communications.

[45]  D. Strunk,et al.  Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow , 2009, Stem cells.

[46]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[47]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[48]  M. Miyazaki,et al.  Effect of c-fos overexpression on development and proliferation of peritoneal B cells. , 2004, International immunology.

[49]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Evan,et al.  Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. , 1985, EMBO Journal.

[51]  R. Hruban,et al.  Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo , 2011, Oncotarget.

[52]  L. Griffith,et al.  Growth factor regulation of proliferation and survival of multipotential stromal cells , 2010, Stem Cell Research & Therapy.

[53]  L. Young,et al.  Mitogenic factors present in serum but not in plasma. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. A. Gomes,et al.  Human serum is a suitable supplement for the osteogenic differentiation of human adipose-derived stem cells seeded on poly-3-hydroxibutyrate-co-3-hydroxyvalerate scaffolds. , 2013, Tissue engineering. Part A.

[55]  Y. Nie,et al.  The Effect of miRNA‐122 in Regulating Fat Deposition in a Cell Line Model , 2014, Journal of cellular biochemistry.

[56]  M. Paz,et al.  Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation , 2008, PloS one.

[57]  Javier León,et al.  Myc and cell cycle control. , 2015, Biochimica et biophysica acta.

[58]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[59]  Baojin Fu,et al.  Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation , 2006, Stem cells.

[60]  Jürgen Frank,et al.  Serum-free cell culture: the serum-free media interactive online database. , 2010, ALTEX.

[61]  G. Rechavi,et al.  Serum Free Cultured Bone Marrow Mesenchymal Stem Cells as a Platform to Characterize the Effects of Specific Molecules , 2010, PloS one.

[62]  Moustapha Kassem,et al.  Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. , 2009, Stem cells and development.

[63]  H. Lawce,et al.  The AGT cytogenetics laboratory manual , 2017 .

[64]  O. Yli-Harja,et al.  Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. , 2010, Tissue engineering. Part A.

[65]  A. C. D. de Paula,et al.  Alkaline Phosphatase Expression/Activity and Multilineage Differentiation Potential are the Differences Between Fibroblasts and Orbital Fat-Derived Stem Cells – A Study in Animal Serum-Free Culture Conditions , 2014, Stem Cell Reviews and Reports.

[66]  G Gstraunthaler,et al.  Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[67]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[68]  M. Kassem,et al.  Human Serum is as Efficient as Fetal Bovine Serum in Supporting Proliferation and Differentiation of Human Multipotent Stromal (Mesenchymal) Stem Cells In Vitro and In Vivo , 2011, Stem Cell Reviews and Reports.

[69]  F. Guilak,et al.  Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells , 2010, Stem Cell Research & Therapy.

[70]  E. Tulchinsky,et al.  Fos family members: regulation, structure and role in oncogenic transformation. , 2000, Histology and histopathology.

[71]  I. Tan,et al.  Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH. , 2014, Cancer letters.

[72]  D. Gomes,et al.  Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. , 2011, Biochemical and biophysical research communications.

[73]  U. Leimer,et al.  Choosing the right type of serum for different applications of human adipose tissue-derived stem cells: influence on proliferation and differentiation abilities. , 2014, Cytotherapy.

[74]  Uma Lakshmipathy,et al.  Development and Characterization of a Clinically Compliant Xeno‐Free Culture Medium in Good Manufacturing Practice for Human Multipotent Mesenchymal Stem Cells , 2012, Stem cells translational medicine.

[75]  A. Katz,et al.  Low serum and serum-free culture of multipotential human adipose stem cells. , 2007, Cytotherapy.

[76]  Sanjin Zvonic,et al.  Immunophenotype of Human Adipose‐Derived Cells: Temporal Changes in Stromal‐Associated and Stem Cell–Associated Markers , 2006, Stem cells.

[77]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[78]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[79]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[80]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[81]  D. Kaigler,et al.  Development of a serum‐free system to expand dental‐derived stem cells: PDLSCs and SHEDs , 2011, Journal of cellular physiology.

[82]  A. Kohara,et al.  Growth factor-defined culture medium for human mesenchymal stem cells. , 2011, The International journal of developmental biology.

[83]  A. Hmadcha,et al.  Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use. , 2014, Stem cells and development.